Choline, An Alternative Therapy For Asthma
Main Category: Respiratory / AsthmaAlso Included In: Allergy; Pharma Industry / Biotech Industry; Pharmacy / Pharmacist
Article Date: 28 Sep 2007 - 5:00 PDT
| Patient / Public: | ![]() |
4.6 (10 votes) |
| Healthcare Prof: | ![]() |
3.67 (3 votes) |
The prevalence of asthma has increased worldwide and current therapies for the disease, such as glucocorticoids, are limited in their usefulness, due to potential side effects.
Bhanu Pratap Singh (Allergy and Immunology Section, Institute of Genomics and Integrative Biology, Delhi, India) and his team examined the anti-inflammatory effects of choline via oral or intranasal routes in mice model of allergic asthma.
Choline treatment inhibits the development of airway hyperresponsiveness (AHR) and eosinophilic inflammation in the lungs. This reduction of AHR is accompanied by a reduction in immunoglobulin E antibody (IgE) and other inflammatory parameters like type 2 T-helper cell (Th2) cytokines, in a manner comparable with current therapy of asthma. Choline treatment also downregulates mucus production and prevents airway obstruction.
Choline is an organic compound, an essential nutrient usually grouped within the Vitamin B complex. This natural amine is found in the lipids that make up cell membranes and in the neurotransmitter acetylcholine.
Increased plasma levels of lysophosphatidyl choline, which play an important role in pathogenesis, were reported in asthmatics. Choline supplementation increases membrane phosphatidyl choline and thereby decreases the mediator release from human basophils.
The results of the present study are encouraging, as choline therapy may enable to substitute or reduce the dosage and side effects of steroid therapy in asthma. However, further studies are required with pre-clinical models of chronic allergic airway disease and subsequent investigations in asthmatics.
The European Respiratory Journal is the peer-reviewed scientific publication of the European Respiratory Society (more than 8,000 specialists in lung diseases and respiratory medicine in Europe, the United States and Australia).
European Respiratory Society
Visit our respiratory / asthma section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/83722.php>
APA
http://www.medicalnewstoday.com/releases/83722.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





